IRIS Accounts Production v24.2.0.383 06491384 Board of Directors 1.1.23 31.12.23 31.12.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh064913842022-12-31064913842023-12-31064913842023-01-012023-12-31064913842021-12-31064913842022-01-012022-12-31064913842022-12-3106491384ns15:EnglandWales2023-01-012023-12-3106491384ns14:PoundSterling2023-01-012023-12-3106491384ns10:Director12023-01-012023-12-3106491384ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3106491384ns10:SmallEntities2023-01-012023-12-3106491384ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3106491384ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3106491384ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3106491384ns10:FullAccounts2023-01-012023-12-310649138412023-01-012023-12-3106491384ns10:Director22023-01-012023-12-3106491384ns10:Director42023-01-012023-12-3106491384ns10:Director52023-01-012023-12-3106491384ns10:RegisteredOffice2023-01-012023-12-3106491384ns5:CurrentFinancialInstruments2023-12-3106491384ns5:CurrentFinancialInstruments2022-12-3106491384ns5:ShareCapital2023-12-3106491384ns5:ShareCapital2022-12-3106491384ns5:SharePremium2023-12-3106491384ns5:SharePremium2022-12-3106491384ns5:RetainedEarningsAccumulatedLosses2023-12-3106491384ns5:RetainedEarningsAccumulatedLosses2022-12-3106491384ns5:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3106491384ns5:PatentsTrademarksLicencesConcessionsSimilar2023-01-012023-12-3106491384ns5:PlantMachinery2023-01-012023-12-3106491384ns5:IntangibleAssetsOtherThanGoodwill2022-12-3106491384ns5:IntangibleAssetsOtherThanGoodwill2023-12-3106491384ns5:IntangibleAssetsOtherThanGoodwill2022-12-3106491384ns5:PlantMachinery2022-12-3106491384ns5:PlantMachinery2023-12-3106491384ns5:PlantMachinery2022-12-3106491384ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3106491384ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3106491384ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2023-12-3106491384ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2022-12-31
REGISTERED NUMBER: 06491384 (England and Wales)








Unaudited Financial Statements

for the Year Ended 31 December 2023

for

ASEP Healthcare Limited

ASEP Healthcare Limited (Registered number: 06491384)






Contents of the Financial Statements
for the Year Ended 31 December 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


ASEP Healthcare Limited

Company Information
for the Year Ended 31 December 2023







DIRECTORS: C V Fellowes
Dr R Kerstein
I S P Mawhinney
S B Seagrave





REGISTERED OFFICE: 18 Tapton Way
Wavertree Business Village
Liverpool
Merseyside
L13 1DA





REGISTERED NUMBER: 06491384 (England and Wales)





ACCOUNTANTS: Jonathan Ford & Co Limited
Chartered Accountants
Maxwell House
Liverpool Innovation Park
Liverpool
Merseyside
L7 9NJ

ASEP Healthcare Limited (Registered number: 06491384)

Balance Sheet
31 December 2023

31.12.23 31.12.22
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 1,201 2,928
Tangible assets 5 6,462 10,884
7,663 13,812

CURRENT ASSETS
Stocks 105,296 111,929
Debtors 6 70,099 234,700
Prepayments and accrued income 20,125 15,594
Cash at bank 44,937 224,102
240,457 586,325
CREDITORS
Amounts falling due within one year 7 180,563 227,205
NET CURRENT ASSETS 59,894 359,120
TOTAL ASSETS LESS CURRENT
LIABILITIES

67,557

372,932

PROVISIONS FOR LIABILITIES 1,608 1,653
NET ASSETS 65,949 371,279

ASEP Healthcare Limited (Registered number: 06491384)

Balance Sheet - continued
31 December 2023

31.12.23 31.12.22
Notes £    £    £    £   
CAPITAL AND RESERVES
Called up share capital 27 27
Share premium 979,931 979,931
Retained earnings (914,009 ) (608,679 )
65,949 371,279

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 4 September 2024 and were signed on its behalf by:





I S P Mawhinney - Director


ASEP Healthcare Limited (Registered number: 06491384)

Notes to the Financial Statements
for the Year Ended 31 December 2023

1. STATUTORY INFORMATION

ASEP Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of nil years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 20% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


ASEP Healthcare Limited (Registered number: 06491384)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 January 2023
and 31 December 2023 71,156
AMORTISATION
At 1 January 2023 68,228
Charge for year 1,727
At 31 December 2023 69,955
NET BOOK VALUE
At 31 December 2023 1,201
At 31 December 2022 2,928

ASEP Healthcare Limited (Registered number: 06491384)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 January 2023
and 31 December 2023 136,210
DEPRECIATION
At 1 January 2023 125,326
Charge for year 4,422
At 31 December 2023 129,748
NET BOOK VALUE
At 31 December 2023 6,462
At 31 December 2022 10,884

6. DEBTORS
31.12.23 31.12.22
£    £   
Amounts falling due within one year:
Trade debtors 33,522 72,248
Other debtors 35,597 43,784
69,119 116,032

Amounts falling due after more than one year:
Other debtors 980 118,668

Aggregate amounts 70,099 234,700

ASEP Healthcare Limited (Registered number: 06491384)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE
YEAR
31.12.23 31.12.22
£    £   
Trade creditors 159,720 101,155
Taxation and social security - 409
Other creditors 20,843 125,641
180,563 227,205

8. OTHER FINANCIAL COMMITMENTS

The company is committed to pay £18,000 inclusive of VAT under non-cancellable operating leases, with £18,000 of this due to be paid within 12 months of the balance sheet date.